BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9681820)

  • 1. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.
    Patel AS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1998 Jun; 16(25):3227-32. PubMed ID: 9681820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.
    Beljkas M; Ilic A; Cebzan A; Radovic B; Djokovic N; Ruzic D; Nikolic K; Oljacic S
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septin 9 Orients the Apico-Basal Polarity Axis and Controls Plasticity Signals.
    Cai T; Peng J; Omrane M; Benzoubir N; Samuel D; Gassama-Diagne A
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A standardized extract of cultured
    Islam S; Kitagawa T; Baron B; Kuhara K; Nagayasu H; Kobayashi M; Chiba I; Kuramitsu Y
    Oncol Lett; 2021 Sep; 22(3):654. PubMed ID: 34386076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of
    Zhao Y; Lei Y; He SW; Li YQ; Wang YQ; Hong XH; Liang YL; Li JY; Chen Y; Luo WJ; Zhang PP; Yang XJ; He QM; Ma J; Liu N; Tang LL
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis.
    Hasan MK; Widhopf GF; Zhang S; Lam SM; Shen Z; Briggs SP; Parker BA; Kipps TJ
    NPJ Breast Cancer; 2019; 5():35. PubMed ID: 31667337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The
    O'Connell ME; Sridharan D; Driscoll T; Krishnamurthy I; Perry WG; Applewhite DA
    Biol Open; 2019 Jun; 8(6):. PubMed ID: 31164339
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells.
    Stock K; Borrink R; Mikesch JH; Hansmeier A; Rehkämper J; Trautmann M; Wardelmann E; Hartmann W; Sperveslage J; Steinestel K
    Cancer Cell Int; 2019; 19():77. PubMed ID: 30976201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.
    Zhang X; Liu K; Zhang T; Wang Z; Qin X; Jing X; Wu H; Ji X; He Y; Zhao R
    Oncotarget; 2017 Jan; 8(1):1541-1554. PubMed ID: 27903975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor and stromal-based contributions to head and neck squamous cell carcinoma invasion.
    Markwell SM; Weed SA
    Cancers (Basel); 2015 Feb; 7(1):382-406. PubMed ID: 25734659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells.
    Wei J; Zhao ZX; Li Y; Zhou ZQ; You TG
    World J Gastroenterol; 2014 Mar; 20(12):3287-300. PubMed ID: 24696610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
    Gattazzo C; Martini V; Frezzato F; Trimarco V; Tibaldi E; Castelli M; Facco M; Zonta F; Brunati AM; Zambello R; Semenzato G; Trentin L
    Haematologica; 2014 Jun; 99(6):1069-77. PubMed ID: 24532043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).
    Radhakrishnan VM; Kojs P; Young G; Ramalingam R; Jagadish B; Mash EA; Martinez JD; Ghishan FK; Kiela PR
    PLoS One; 2014; 9(1):e85796. PubMed ID: 24465712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invading one step at a time: the role of invadopodia in tumor metastasis.
    Paz H; Pathak N; Yang J
    Oncogene; 2014 Aug; 33(33):4193-202. PubMed ID: 24077283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.
    Kalakonda S; Nallar SC; Lindner DJ; Sun P; Lorenz RR; Lamarre E; Reddy SP; Kalvakolanu DV
    Oncogene; 2014 Jun; 33(24):3195-204. PubMed ID: 23851499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.
    Zhao G; Huang ZM; Kong YL; Wen DQ; Li Y; Ren L; Zhang HY
    World J Surg Oncol; 2013 Mar; 11():74. PubMed ID: 23518204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
    Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
    J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortactin in cell migration and cancer at a glance.
    MacGrath SM; Koleske AJ
    J Cell Sci; 2012 Apr; 125(Pt 7):1621-6. PubMed ID: 22566665
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of CTTN polymorphisms with the risk of colorectal cancer.
    Lee SY; Kang DB; Park WC; Lee JK; Chae SC
    J Korean Surg Soc; 2012 Mar; 82(3):156-64. PubMed ID: 22403749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homolog of the five SH3-domain protein (HOFI/SH3PXD2B) regulates lamellipodia formation and cell spreading.
    Lányi Á; Baráth M; Péterfi Z; Bogel G; Orient A; Simon T; Petrovszki E; Kis-Tóth K; Sirokmány G; Rajnavölgyi É; Terhorst C; Buday L; Geiszt M
    PLoS One; 2011; 6(8):e23653. PubMed ID: 21886807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.